Subscribe
Biofrontera advances closer to expanding the Ameluz PDT label, as phase 3 follow-up data on actinic keratoses are expected next year.
FDA Approves Sun Pharma's New LED BLU-U Device for AK
“Hats On” Challenge Unites Dermatology Community to Spotlight Actinic Keratosis Ahead of Global Awareness Day
Immunocompromised Patients with Actinic Keratosis Respond Well to LED Daylight Photodynamic Combination Therapy
Torqur AG Reports Promising Phase 2 Results for Bimiralisib Gel in Actinic Keratosis
Joseph Gorelick, MSN, FNP-C
Brad P. Glick, DO, MPH, FAAD
Hilary Baldwin; Neal Bhatia, MD
Tina Bhutani, MD
June 17-19, 2026
Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD
Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc
Andrew Alexis, MD, MPH; Leon Kircik, MD
Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD
Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD